Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls.
BACKGROUND
Cystoid macular edema (CME) is a well-known complication after cataract surgery, and diabetic retinopathy is reported to be an important risk factor for impaired visual recovery. In this prospective study, we compared visual outcome 6 months after surgery in eyes with moderate retinopathy and no previous ME with a control group, and observed the incidence of ME seen on fluorescein angiography (FA) and optical coherence tomography (OCT).


METHODS
Thirty-four patients with type-2 diabetes and 35 controls were enrolled. Best-corrected visual acuity (VA) letters ETDRS was measured pre-op, at day 7, week 6 and month 6. FA performed pre-op and at week 6 was divided into three leakage patterns. OCT performed pre-op, at week 6 and month 6 was qualitatively divided into three types. Macular thickness was measured in three circular fields (central subfield, inner and outer circle) from the macular maps.


RESULTS
There was no statistically significant difference in VA before surgery, at day 7 or at 6 months, but at 6 weeks there was a significant difference with lower VA in the diabetic group. Six percent of control and 12% of diabetic eyes developed a clinical CME defined as a loss of >5 letters between day 7 and week 6. Incidence of FA leakage was 23% in control and 76% in diabetic eyes. At 6 weeks, 20% of control and 44% of the diabetic eyes had qualitative changes on OCT. A statistically significant increase in thickness was observed for all three macular areas in both groups, part of it remaining at 6 months. There were, however, no differences in central macular thickness between the groups at any visit. Retinal thickening had poor correlation with VA.


CONCLUSIONS
The final visual outcome in eyes with mild to moderate retinopathy, without previous ME, is as good as in normal eyes, but an increased frequency of macular changes may protract recovery of full vision. Changes on OCT or FA are often seen without any obvious effect on VA. OCT is as good as FA at detecting a clinical CME, and is the technique recommended for follow-up before FA is considered.
Eriksson
Urban
U
Department of Neuroscience, Ophthalmology, Uppsala University, Akademiska sjukhuset, 751 85, Uppsala, Sweden.
Alm
Albert
A
Bjärnhall
Gunilla
G
Granstam
Elisabet
E
Matsson
Anna Wikberg
AW
D000368:Aged; D000369:Aged, 80 and over; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003930:Diabetic Retinopathy / Q000503:physiopathology*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D015994:Incidence; D019654:Lens Implantation, Intraocular; D008269:Macular Edema / Q000175:diagnosis / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D011183:Postoperative Complications; D011446:Prospective Studies; D041623:Tomography, Optical Coherence; D014792:Visual Acuity / Q000502:physiology*
Ophthalmology. 1998 Feb;105(2):360-70
9479300
Arch Ophthalmol. 1995 Aug;113(8):1019-29
7639652
Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):18-23
16865374
Am J Ophthalmol. 1999 Jun;127(6):688-93
10372879
Arch Ophthalmol. 2001 Aug;119(8):1135-42
11483079
Acta Ophthalmol Scand. 2002 Feb;80(1):19-24
11906299
Am J Ophthalmol. 1953 May;36(5):599-619
13040458
Ophthalmology. 1991 May;98(5 Suppl):786-806
2062513
Arch Ophthalmol. 1985 Dec;103(12):1796-806
2866759
Arch Ophthalmol. 2006 Feb;124(2):193-8
16476888
Br J Ophthalmol. 2002 May;86(5):565-71
11973256
Arch Ophthalmol. 1966 Nov;76(5):646-61
5955948
Curr Opin Ophthalmol. 2009 Jan;20(1):46-51
19093330
Ophthalmology. 2004 Apr;111(4):712-5
15051203
Trans Am Ophthalmol Soc. 1998;96:557-634
10360304
Ophthalmology. 2007 Mar;114(3):525-36
17123615
Graefes Arch Clin Exp Ophthalmol. 2002 Sep;240(9):735-8
12271370
Eur J Ophthalmol. 2002 Mar-Apr;12(2):102-8
12022281
Clin Exp Ophthalmol. 2006 Mar;34(2):124-9; quiz 194
16626425
Clin Exp Ophthalmol. 2005 Jun;33(3):240-5
15932526
J Cataract Refract Surg. 2006 May;32(5):803-11
16765799
Arch Ophthalmol. 2005 Oct;123(10):1330-7
16219723
Surv Ophthalmol. 1984 May;28 Suppl:535-9
6379951
Am J Ophthalmol. 1976 May;81(5):614-5
1275040
Br J Ophthalmol. 1996 Sep;80(9):789-93
8942374
Acta Ophthalmol. 2009 Nov;87(7):725-30
18937816
Am J Ophthalmol. 2004 Feb;137(2):313-22
14962423
Ophthalmology. 2007 May;114(5):881-9
17275910
Retina. 2002 Dec;22(6):759-67
12476103
Retina. 2008 Jun;28(6):870-6
18536605
Ophthalmologica. 2003 Nov-Dec;217(6):408-12
14573973
Science. 1991 Nov 22;254(5035):1178-81
1957169
Ophthalmology. 1999 Apr;106(4):663-8
10201584
Arch Ophthalmol. 1995 Mar;113(3):325-32
7887846
J Cataract Refract Surg. 1999 Feb;25(2):256-61
9951674
Int Ophthalmol. 2005 Jun;26(3):93-9
17063373
Curr Opin Ophthalmol. 2000 Feb;11(1):65-72
10724830
Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1765-71
17619896
Ger J Ophthalmol. 1996 Mar;5(2):79-83
8741151
Br J Ophthalmol. 1992 Apr;76(4):221-4
1390489
Acta Ophthalmol. 2008 Feb;86(1):34-9
17651471
Semin Ophthalmol. 2002 Sep-Dec;17(3-4):167-80
12759847
J Cataract Refract Surg. 1999 Nov;25(11):1492-7
10569164
J Cataract Refract Surg. 2002 Apr;28(4):626-30
11955902
Acta Ophthalmol Scand. 2007 Sep;85(6):613-7
17408388
Arch Ophthalmol. 2004 Mar;122(3):330-5
15006844
Eye (Lond). 2006 Mar;20(3):297-303
15818389
J Cataract Refract Surg. 2004 Apr;30(4):752-60
15093635
Ophthalmic Surg. 1991 Apr;22(4):190-3
2057179